Scientific ReportsCancer BiologyPeer-reviewed journal article
Hyaluronidase inhibitor delphinidin inhibits cancer metastasis
Jeremy McGuireiD, Taketo Taguchi, Gregory Tombline, Victoria PaigeiD, Michelle C. JanelsinsiD, Nikesha J. GilmoreiD, Andrei SeluanoviD, Vera A. GorbunovaiD
- Citations
- 18
- FWCI
- 2.72
- Field percentile
- top 9%
Abstract
Cancer remains a formidable global health challenge, with metastasis being a key contributor to its lethality. Abundant high molecular mass hyaluronic acid, a major non-protein component of extracellular matrix, protects naked mole rats from cancer and reduces cancer incidence in mice. Hyaluronidase plays a critical role in degrading hyaluronic acid and is frequently overexpressed in metastatic cancer. Here we investigated the potential of targeting hyaluronidases to reduce metastasis. High throughput screen identified delphinidin, a natural plant compound found in fruits and vegetables, as a potent hyaluronidase inhibitor. Delphinidin-mediated inhibition of hyaluronidase activity led to an increase in high molecular weight hyaluronic acid in cell culture and in mouse tissues, and reduced migration and invasion behavior of breast, prostate, and melanoma cancer cells. Moreover, delphinidin treatment suppressed melanoma metastasis in mice. Our study provides a proof of principle that inhibition of hyaluronidase activity suppresses cancer cell migration, invasion and metastasis. Furthermore, we identify a natural compound delphinidin as a potential anticancer therapeutic. Thus, we have identified a path for clinical translation of the cancer resistance mechanism identified in the naked mole rat.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A genome-wide CRISPR screen reveals cancer-specific regulators of hyaluronan binding and cellular invasion
Jimmy Kim, Halen Kovacs, … Simon Wisnovsky·bioRxiv·Feb 9, 2026
- Identification of Hyal2-expressing tumor-associated myeloid cells in cancer: implications for cancer-related inflammation through enhanced hyaluronan degradation
P. R. G. Dominguez, E. Kwenda, … S. Kusmartsev·bioRxiv·Sep 14, 2020
- Scaffold Protein RACK1 inhibitor compounds prevent the Focal Adhesion Kinase mediated breast cancer cell migration and invasion potential
H. Ullah, N. Ahsan, S. Dakshanamurthy·bioRxiv·Jun 13, 2021
- Impaired migration and metastatic spread of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR
V. Lopes-Rodrigues, S. A. Nyantakyi, … C. F. Ibanez·bioRxiv·Nov 13, 2023
- Tubulin-Targeted Therapy in Melanoma Increases Cell Invasive Potential by Activation of Actomyosin Cytoskeleton - an in vitro study
Marcin Luty, Renata Szydlak, … Bartłomiej Zapotoczny·ACS Biomaterials Science & EngineeringPeer-reviewed·Oct 22, 2024
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer
Alejandro Rodríguez Martínez, Lucía Giraldo-Ruiz, … Horacio Pérez‐Sánchez·Scientific ReportsPeer-reviewed·Apr 28, 2025